In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons

Cell Systems

Volumn 4, Issue 2, 2017, Pages 242-250.e4

  Chung, Chee Yeun ^a   Khurana, Vikram ^a,b,c   Yi, Song ^d,e   Sahni, Nidhi ^d,e   Loh, Ken H ^f   Auluck, Pavan K ^a   Baru, Valeriya ^a   Udeshi, Namrata D ^g   Freyzon, Yelena ^a   Carr, Steven A ^g   Hill, David E ^d,e   Vidal, Marc ^d,e   Ting, Alice Y ^f   Lindquist, Susan ^a,f  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ASCORBATE PEROXIDASE; BINDING PROTEIN; MESSENGER RNA; PEROXIDASE; PHOSPHATASE; PROTEOME; HYDROGEN PEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOSOME; GENE INTERACTION; MASS SPECTROMETRY; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; RNA METABOLISM; RNA TRANSLATION; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; HEK293 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT;

ALPHA-SYNUCLEIN; ANIMALS; ASCORBATE PEROXIDASES; CELLS, CULTURED; HEK293 CELLS; HUMANS; HYDROGEN PEROXIDE; MASS SPECTROMETRY; NEURONS; PARKINSON DISEASE; PROTEIN TRANSPORT; RATS; RNA, MESSENGER;

EID: 85010509567     PISSN: 24054712     EISSN: 24054720     Source Type: Journal    
DOI: 10.1016/j.cels.2017.01.002     Document Type: Article

References (45)

1. Auluck, P.K., Caraveo, G., Lindquist, S., α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu. Rev. Cell Dev. Biol. 26 (2010), 211–233.
2. Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M.R., Südhof, T.C., Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329 (2010), 1663–1667.
3. Burré, J., Sharma, M., Südhof, T.C., α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. USA 111 (2014), E4274–E4283.
4. Cartier, A.E., Ubhi, K., Spencer, B., Vazquez-Roque, R.A., Kosberg, K.A., Fourgeaud, L., Kanayson, P., Patrick, C., Rockenstein, E., Patrick, G.N., Masliah, E., Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy. PLoS ONE, 7, 2012, e34713.
5. Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O.M., Südhof, T.C., Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123 (2005), 383–396.
6. Choi, P., Golts, N., Snyder, H., Chong, M., Petrucelli, L., Hardy, J., Sparkman, D., Cochran, E., Lee, J.M., Wolozin, B., Co-association of parkin and alpha-synuclein. Neuroreport 12 (2001), 2839–2843.
7. Chung, C.Y., Koprich, J.B., Hallett, P.J., Isacson, O., Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proc. Natl. Acad. Sci. USA 106 (2009), 22474–22479.
8. Chung, C.Y., Khurana, V., Auluck, P.K., Tardiff, D.F., Mazzulli, J.R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al. Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science 342 (2013), 983–987.
9. Davidson, W.S., Jonas, A., Clayton, D.F., George, J.M., Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998), 9443–9449.
10. Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y.I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A., et al. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS ONE, 7, 2012, e36458.
11. Ekholm-Reed, S., Goldberg, M.S., Schlossmacher, M.G., Reed, S.I., Parkin-dependent degradation of the F-box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1. Mol. Cell. Biol. 33 (2013), 3627–3643.
12. Engelender, S., Kaminsky, Z., Guo, X., Sharp, A.H., Amaravi, R.K., Kleiderlein, J.J., Margolis, R.L., Troncoso, J.C., Lanahan, A.A., Worley, P.F., et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22 (1999), 110–114.
13. Gitler, A.D., Bevis, B.J., Shorter, J., Strathearn, K.E., Hamamichi, S., Su, L.J., Caldwell, K.A., Caldwell, G.A., Rochet, J.C., McCaffery, J.M., et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA 105 (2008), 145–150.
14. Goedert, M., Spillantini, M.G., Del Tredici, K., Braak, H., 100 years of Lewy pathology. Nat. Rev. Neurol. 9 (2013), 13–24.
15. Greten-Harrison, B., Polydoro, M., Morimoto-Tomita, M., Diao, L., Williams, A.M., Nie, E.H., Makani, S., Tian, N., Castillo, P.E., Buchman, V.L., Chandra, S.S., αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl. Acad. Sci. USA 107 (2010), 19573–19578.
16. Hung, V., Zou, P., Rhee, H.W., Udeshi, N.D., Cracan, V., Svinkina, T., Carr, S.A., Mootha, V.K., Ting, A.Y., Proteomic mapping of the human mitochondrial intermembrane space in live cells via ratiometric APEX tagging. Mol. Cell 55 (2014), 332–341.
17. Hunn, B.H.M., Cragg, S.J., Bolam, J.P., Spillantini, M.G., Wade-Martins, R., Impaired intracellular trafficking defines early Parkinson's disease. Trends Neurosci. 38 (2015), 178–188.
18. Ivatt, R.M., Sanchez-Martinez, A., Godena, V.K., Brown, S., Ziviani, E., Whitworth, A.J., Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy. Proc. Natl. Acad. Sci. USA 111 (2014), 8494–8499.
19. Jensen, P.H., Hager, H., Nielsen, M.S., Hojrup, P., Gliemann, J., Jakes, R., alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274 (1999), 25481–25489.
20. Khurana, V., Peng, J., Chung, C.Y., Auluck, P.K., Fanning, S., Tardiff, D.F., Bartels, T., Koeva, M., Eichhorn, S.W., Benyamini, H., et al. Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways. Cell Syst., 4, 2017, 10.1016/j.cels.2016.12.011.
21. Kim, H.J., Kim, N.C., Wang, Y.D., Scarborough, E.A., Moore, J., Diaz, Z., MacLea, K.S., Freibaum, B., Li, S., Molliex, A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495 (2013), 467–473.
22. Kontopoulos, E., Parvin, J.D., Feany, M.B., Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15 (2006), 3012–3023.
23. Köroğlu, Ç., Baysal, L., Cetinkaya, M., Karasoy, H., Tolun, A., DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat. Disord. 19 (2013), 320–324.
24. Krebs, C.E., Karkheiran, S., Powell, J.C., Cao, M., Makarov, V., Darvish, H., Di Paolo, G., Walker, R.H., Shahidi, G.A., Buxbaum, J.D., et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum. Mutat. 34 (2013), 1200–1207.
25. Lam, S.S., Martell, J.D., Kamer, K.J., Deerinck, T.J., Ellisman, M.H., Mootha, V.K., Ting, A.Y., Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat. Methods 12 (2015), 51–54.
26. Liu, Z., Meray, R.K., Grammatopoulos, T.N., Fredenburg, R.A., Cookson, M.R., Liu, Y., Logan, T., Lansbury, P.T. Jr., Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc. Natl. Acad. Sci. USA 106 (2009), 4635–4640.
27. Maroteaux, L., Campanelli, J.T., Scheller, R.H., Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8 (1988), 2804–2815.
28. McFarland, M.A., Ellis, C.E., Markey, S.P., Nussbaum, R.L., Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol. Cell. Proteomics 7 (2008), 2123–2137.
29. Mizuno, N., Varkey, J., Kegulian, N.C., Hegde, B.G., Cheng, N., Langen, R., Steven, A.C., Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation. J. Biol. Chem. 287 (2012), 29301–29311.
30. Müller-Kuller, U., Ackermann, M., Kolodziej, S., Brendel, C., Fritsch, J., Lachmann, N., Kunkel, H., Lausen, J., Schambach, A., Moritz, T., Grez, M., A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells. Nucleic Acids Res. 43 (2015), 1577–1592.
31. Nakai, M., Fujita, M., Waragai, M., Sugama, S., Wei, J., Akatsu, H., Ohtaka-Maruyama, C., Okado, H., Hashimoto, M., Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. Biochem. Biophys. Res. Commun. 358 (2007), 104–110.
32. Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., DeStefano, A.L., Kara, E., Bras, J., Sharma, M., et al. International Parkinson's Disease Genomics Consortium (IPDGC) Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI) 23andMe GenePD NeuroGenetics Research Consortium (NGRC) Hussman Institute of Human Genomics (HIHG) Ashkenazi Jewish Dataset Investigator Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE) North American Brain Expression Consortium (NABEC) United Kingdom Brain Expression Consortium (UKBEC) Greek Parkinson's Disease Consortium, Alzheimer Genetic Analysis Group. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46 (2014), 989–993.
33. Olgiati, S., De Rosa, A., Quadri, M., Criscuolo, C., Breedveld, G.J., Picillo, M., Pappatà, S., Quarantelli, M., Barone, P., De Michele, G., Bonifati, V., PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family. Neurogenetics 15 (2014), 183–188.
34. Olgiati, S., et al. DNAJC6 mutations associated with early-onset Parkinson's disease. Ann. Neurol., 2015.
35. Quadri, M., Fang, M., Picillo, M., Olgiati, S., Breedveld, G.J., Graafland, J., Wu, B., Xu, F., Erro, R., Amboni, M., et al., International Parkinsonism Genetics Network. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum. Mutat. 34 (2013), 1208–1215.
36. Rhee, H.W., Zou, P., Udeshi, N.D., Martell, J.D., Mootha, V.K., Carr, S.A., Ting, A.Y., Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging. Science 339 (2013), 1328–1331.
37. Scott, D.A., Tabarean, I., Tang, Y., Cartier, A., Masliah, E., Roy, S., A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J. Neurosci. 30 (2010), 8083–8095.
38. Sharma, M., Burré, J., Bronk, P., Zhang, Y., Xu, W., Südhof, T.C., CSPα knockout causes neurodegeneration by impairing SNAP-25 function. EMBO J. 31 (2012), 829–841.
39. Shulman, J.M., De Jager, P.L., Feany, M.B., Parkinson's Disease: Genetics and Pathogenesis. Annu. Rev. Pathol., 2010.
40. Stagljar, I., Korostensky, C., Johnsson, N., te Heesen, S., A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. USA 95 (1998), 5187–5192.
41. Taylor, J.P., Multisystem proteinopathy: intersecting genetics in muscle, bone, and brain degeneration. Neurology 85 (2015), 658–660.
42. Udeshi, N.D., Mertins, P., Svinkina, T., Carr, S.A., Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 8 (2013), 1950–1960.
43. Vargas, K.J., Makani, S., Davis, T., Westphal, C.H., Castillo, P.E., Chandra, S.S., Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci. 34 (2014), 9364–9376.
44. Yasuda, T., Nihira, T., Ren, Y.R., Cao, X.Q., Wada, K., Setsuie, R., Kabuta, T., Wada, K., Hattori, N., Mizuno, Y., Mochizuki, H., Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease. J. Neurochem. 108 (2009), 932–944.
45. Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S.H., Offman, M.N., Haubenberger, D., Spielberger, S., Schulte, E.C., Lichtner, P., et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89 (2011), 168–175.